Home/ Supplements/ Niacin/ Vasotropin

Vasotropin

product on market Tablet or Pill Gaspari Nutrition Safety: 92/100
92/100

This product looks safe

  • Niacin: 200mg is 5.7× the Tolerable Upper Intake Level (35mg)
  • 20% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains niacin and calcium, which support metabolic function and muscle contraction. The proprietary Vasotropin and NOSPEP blends target blood flow, though research evidence for these specific branded complexes is limited. Overall, the ingredient profile is supported by moderate evidence for general vascular support.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 200mg is 5.7× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Vasotropin
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
40
Servings
Other Combinations
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

200 mg (1000% DV)
Exceeds UL by 5.7× (UL: 35 mg) 196 studies (A:5, B:63)
Calcium
126 mg (13% DV)
Sodium
124 mg (6% DV)
NOSPEP(TM)
123 mg
Vasotropin(TM) Proprietary Blend
1475 mg

Other Ingredients

Sodium Starch Glycolate Magnesium Stearate Silicon Dioxide Talc
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

SUGGESTED USE: As a dietary supplement, take three (3) to six (6) capsules with a carbohydrate containing meal such as your pre-workout meal.

Warnings & Precautions

Before using this product seek the advice of a physician. Do not use if you are taking erectile dysfunction medication. Do not take additional nitrates in the form of medication or dietary supplements along with this product.

Do not exceed the suggested amount (three capsules twice per day) under any circumstances as this will not increase benefits. This product should be used in conjunction with a proper diet and exercise programs. Before starting any exercise program or new diet plan, consult with your physician. Immediately discontinue use and call your physician if you experience any adverse reactions.

KEEP OUT OF REACH OF CHILDREN.†

Please use ONLY as directed for the best results.

Consult with your health care provider before using this product, especially if you are taking any prescription, over the counter medication, other dietary supplement products and/or if you have any pre-existing medical condition including but not limited to: high or low blood pressure, cardiac arrhythmia, stroke, heart, liver, kidney or thyroid disease, seizure disorder, psychiatric disease, diabetes or any other medication or product.

Formulation Notes

WARNING: This dietary supplement is only intended to be used by healthy men 18+ years of age.

CONTAINS: MILK.

Additional Information

{QR Code} For an in depth look into VASOTROPIN(TM), scan the QR code with a QR code application on your smartphone. The Gaspari R&D team prides itself on formulating the absolute best supplements based on the most cutting edge research.

Full Month Supply

THE ULTIMATE PUMP SOLUTION

REV. 1111

Metadata

Product Details

UPC / SKU6 46511 00770 3
DSLD Entry Date2013-02-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID18404
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.